TSS
CARM

Two Sigma Securities’s Carisma Therapeutics CARM Stock Holding History

Two Sigma Securities’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,828
Closed -$3.52K – 1523
2025
Q3 		$3.52K Sell
12,828
-5,124
-29% -$1.69K ﹤0.01% 1267
2025
Q2 		$7.03K Buy
17,952
+6,338
+55% +$1.7K ﹤0.01% 1331
2025
Q1 		$3.6K Buy
11,614
+182
+2% +$81 ﹤0.01% 1323
2024
Q4 		$4.79K Buy
+11,432
New +$9.42K ﹤0.01% 1486
2023
Q1 		– Sell
-4,185
Closed -$51K – 2699
2022
Q4 		$51K Buy
+4,185
New +$43.9K ﹤0.01% 2158
2022
Q3 		– Sell
-1,989
Closed -$32K – 2636
2022
Q2 		$32K Buy
1,989
+1,125
+130% +$12.9K ﹤0.01% 1893
2022
Q1 		$10K Sell
864
-2,847
-77% -$39.8K ﹤0.01% 2042
2021
Q4 		$60K Sell
3,711
-2,821
-43% -$56.8K ﹤0.01% 1251
2021
Q3 		$104K Buy
+6,532
New +$313K ﹤0.01% 1309
2020
Q4 		– Sell
-1,021
Closed -$29K – 1682
2020
Q3 		$29K Buy
+1,021
New +$20.4K ﹤0.01% 1223
2019
Q3 		– Sell
-1,982
Closed -$59K – 2076
2019
Q2 		$59K Buy
+1,982
New +$59.3K ﹤0.01% 1883
2018
Q3 		– Sell
-573
Closed -$22K – 2605
2018
Q2 		$22K Buy
+573
New +$25.2K ﹤0.01% 2557
2018
Q1 		– Sell
-3,258
Closed -$53K – 2681
2017
Q4 		$53K Buy
+3,258
New +$60.6K ﹤0.01% 1518
2017
Q3 		– Sell
-874
Closed -$27K – 946
2017
Q2 		$27K Buy
+874
New +$29.1K 0.01% 766
2016
Q3 		– Sell
-1,271
Closed -$42K – 667
2016
Q2 		$42K Buy
1,271
+99
+8% +$2.5K 0.02% 345
2016
Q1 		$7K Buy
+1,172
New +$16.2K 0.01% 271

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Two Sigma Securities's CARM Position: Q4 2025 in Review

Two Sigma Securities sold out of Carisma Therapeutics (CARM) in Q4 2025, closing a stake of 12,828 shares — an estimated $3.52K sold.

Two Sigma Securities first reported a position in CARM in Q1 2016 and held it in 16 quarters. The position peaked at $104K in Q3 2021. 7 funds tracked by Wall St. Rank hold CARM as of Q4 2025.

  • Two Sigma Securities reported no remaining Carisma Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 12,828 Carisma Therapeutics shares in Q4 2025, an estimated $3.52K.
  • Two Sigma Securities first reported a position in Carisma Therapeutics in Q1 2016 and held it in 16 quarters.
  • Two Sigma Securities's Carisma Therapeutics position peaked at $104K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.